サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1138416

血管損傷治療の世界市場-2022-2029

Global Vascular Injury Treatment Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
血管損傷治療の世界市場-2022-2029
出版日: 2022年10月18日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

血管損傷治療の世界市場の成長は、血管損傷の数が増加すれば、血管損傷治療のニーズも増加するなどの特定の要因に左右されます。交通事故、犯罪、傷害の数が増加すると、血管損傷の発生率も増加し、血管損傷の治療に対する需要を提供します。イノベーションとヘルスケア産業に対する国の支援は拡大し、事業拡大を後押ししています。

主要ヘルスケアプロバイダー間のパートナーシップにより、予測期間中、世界の血管損傷治療市場を牽引する見込み

心臓関連疾患の臨床治療を提供するための病院との提携が増加していることから、世界の血管損傷治療市場は予測期間中に大きく拡大すると予測されます。例えば、Mayo Clinic Health SystemとOU Children's Hospitalは、2019年に希少な心臓病の調査について提携しました。（左心低形成症候群）。さらに、世界中の多くの病院と連携して、希少な心臓病の対策に取り組んでいます。さらに、メイヨークリニック、フィラデルフィア小児病院、ロサンゼルス小児病院、ミネソタ小児病院、コロラド小児病院の5つのHypoplastic Left Heart Syndrome（HLHS）コンソーシアム参加者とパートナーシップを結びました。Mayo Clinic Health Systemは、2018年にEkoと協力し、潜在的にリスクの高い心臓病を特定するために医師を支援するデータ駆動型技術を開発しました。また、EkoとMayo Clinicは、患者の低駆出率（心臓のポンプが弱い）の診断を支援する機械ベースのアルゴリズムを構築し、商業化する計画を発表しています。その結果、心臓病を検出するための新技術がさらに登場し、世界の血管損傷治療市場は予測期間中に速いペースで拡大すると予測されます。世界保健機関（WHO）によると、毎年1,790万人が心血管系疾患で死亡しています。その結果、予測期間中に世界の血管損傷治療市場の成長を促進すると予測される理由の1つは、心血管疾患の有病率の増加です。

血管治療に伴う高コストが血管損傷治療市場の成長を阻む

しかし、世界の血管損傷治療産業の発展を妨げると予測される主な理由の1つは、血管疾患治療に関連する高コストです。例えば、末梢動脈疾患（PAD）に関連する非冠動脈処置の総費用は729米ドルです。さらに、降圧治療の平均コストは313米ドルで、脂質低下療法の平均コストは207米ドルです。さらに、米国心臓協会（AHA）によると、米国における心血管治療の総コストは、2035年までに1兆1,000億米ドルを超えると予想されています。

産業分析

世界の血管損傷治療市場は、ポーターのファイブフォース分析、サプライチェーン分析、規制分析、価格分析、償還分析、アンメットニーズ、特許動向など、様々な産業要因に基づく市場の詳細な分析を提供しています。

世界の血管損傷治療市場レポートでは、約40以上の市場データ表、45以上の図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

  • 傷害別市場内訳
  • 治療方法別市場内訳
  • 地域別市場内訳

第4章 市場の力学

  • 市場影響要因
    • 促進要因
      • 高度な治療法に対する需要の高まり
    • 抑制要因
      • 効果的な治療法の欠如
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • バリューチェーン分析
  • PEST分析
  • プライシング分析
  • 法規制分析
  • 保険償還分析
  • アンメットニーズ
  • 特許動向

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、あるいは将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • まとめ

第7章 傷害別

  • 血栓症
  • 挫傷/内膜フラップ
  • 裂傷/断裂
  • 痙攣
  • 動脈瘤と仮性動脈瘤
  • 動静脈瘻（AV）
  • その他

第8章 治療法別

  • パッチ血管形成術
  • 側方前膜切開術/静脈切開術
  • バイパスグラフト
  • 血栓除去術
  • 解剖学的外径バイパス術
  • その他

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第10章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A（合併・買収）分析

第11章 企業プロファイル

  • Cleveland Clinic
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Massachusetts General Hospital
  • Heidelberg University Hospital
  • Royal Berkshire NHS Foundation Trust
  • Mayo Clinic Health System
  • Tenet Healthcare
  • Apollo Hospitals Enterprise Ltd.
  • Universal Health Services, Inc.
  • Mediclinic International
  • CHSPSC, LLC（*List Is Not Exhaustive）

第12章 重要考察

第13章 DataM

目次
Product Code: DMPH2589

Market Overview

Vascular Injury Treatment Market size was valued at US$ 3.04 billion in 2021 and is estimated to reach US$ 5.05 million by 2029, growing at a CAGR of 6.2% during the forecast period (2022-2029).

Vascular injury happens when a blood artery is damaged (artery and veins). In addition, vascular surgeons identify these injuries according to the type of wound that caused them, such as a blunt or penetrating injury. A blunt injury happens when a blood vessel is squeezed or crushed, while a penetrating injury occurs when a blood vessel is punctured, torn, or severed. Furthermore, a blunt or penetrating injury may result in a life-threatening hemorrhage. Blood clots can be severe if they break off and migrate to other areas of the body, such as the lungs and brain, resulting in ischemic strokes and pulmonary embolism. The most frequent cause of peripheral artery injury is blunt or penetrating damage to the extremities. These injuries, which damage the main arteries, nerves, and veins, may have negative impacts if they are not identified and handled immediately, leading to long-term injury and deformity.

Market Dynamics

The global vascular injury treatment market growth driven by certain factors such by the number of vascular injuries increases, so does the need for vascular injury care. When the number of traffic collisions, crime, and injuries increases, so does the incidence of vascular injury damage, providing a demand for vascular injury care. State support for innovation and the healthcare industry has been expanded, which has aided business expansion.

Partnerships between major healthcare providers, is expected to drive the global vascular injury treatment market during the forecast period

Owing to an increase in hospital partnerships to provide clinical treatments for heart-associated disorders, the global vascular injury care market is projected to expand significantly over the forecast period. For example, Mayo Clinic Health System and OU Children's Hospital partnered on rare heart disease research in 2019. (Hypoplastic Left Heart Syndrome). Furthermore, they are working with a wide number of hospitals around the world to combat rare heart disease. Furthermore, Mayo Clinic, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Children's Minnesota, and Children's Hospital Colorado partnered with five other Hypoplastic Left Heart Syndrome (HLHS) Consortium participants, including Mayo Clinic, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Children's Minnesota, and Children's Hospital Colorado. Mayo Clinic Health System has collaborated with Eko in 2018 to develop data-driven technologies that would assist doctors in identifying potentially risky heart diseases. Eko and Mayo Clinic have also announced plans to build and commercialize a machine-based algorithm that will assist in the diagnosis of low ejection fraction in patients (a weak heart pump). As a result, the global vascular injury treatment market is projected to expand at a faster pace over the forecast period as more new technology for detecting heart disease is launched. According to the World Health Organisation, 17.9 million people die each year from cardiovascular disease. As a result, one of the reasons projected to fuel growth in the global vascular injury care market over the forecast period is the growing prevalence of cardiovascular disease.

High cost associated with vascular treatment hampering the growth of the vascular injury treatment market

However, one of the main reasons projected to hinder the development of the global vascular injury care industry is the high cost associated with vascular disease treatment. For eg, the total cost of non-coronary procedures linked to peripheral artery disease (PAD) is US$ 729. Furthermore, the average cost of antihypertensive treatment is USD 313, while the average cost of lipid-lowering therapy is USD 207. Furthermore, according to the American Heart Association (AHA), the overall cost of cardiovascular care in the U.S. is expected to exceed USD 1.1 trillion by 2035.

Industry Analysis

The global vascular injury treatment market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, reimbursement analysis, unmet needs and patent trends etc.

Segment Analysis

The bypass graft segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The bypass graft segment continues significant dominance due to features such as elevated occurrence rates and health problems associated with vascular diseases. The most serious vascular diseases include stroke, arteriovenous malformation (AVM), peripheral artery disease (PAD), carotid artery disease (CAD), abdominal aortic aneurysm (AAA), pulmonary embolism, critical limb ischemia (CLI), deep vein thrombosis (DVT), varicose veins, and chronic venous insufficiency (CVI). According to the National Institutes of Health (NIH), coronary heart disease affects approximately 14 million men and women in the United States. It is most prominent in people over the age of 65. Plaque, a waxy material that accumulates blood to the heart muscle inside the lungs, induces the condition. The most effective treatment for artery damage is a bypass graft to enhance poor blood supply to the heart. Individuals with obstructive coronary artery disease, a type of ischemic heart disease, can benefit from this surgery because it decreases the risk of serious complications. As a result, demand for bypass grafts is growing, propelling market growth over the projected period.

Geographical Analysis

North America region holds the largest market share of the global vascular injury treatment market

Throughout the forecast period, North America is anticipated to continue its dominance in the overall vascular injury treatment market. During the forecast period, the growing prevalence of vascular diseases is projected to be the major factor driving the market's overall growth. Furthermore, the geriatric population in the United States is increasing, which is expected to increase the demand for peripheral vascular care in the region. According to the Centers for Disease Control and Prevention (CDC), about 8.5 million individuals in the United States suffer from peripheral artery disease, with 12 percent -20 percent of those above the age of 60 suffering from the disease. These are also some of the major reasons maintaining the region's dominance.

Competitive Landscape

The vascular injury treatment market is moderately competitive, owing to the presence of major market players in the key regions such as US, China, India and others. The key vascular injury treatment players which are contributing to the growth of the global market include Cleveland Clinic, Massachusetts General Hospital, Heidelberg University Hospital, Royal Berkshire NHS Foundation Trust, Mayo Clinic Health System, Tenet Healthcare, Apollo Hospitals Enterprise Ltd., Universal Health Services, Inc., Mediclinic International, CHSPSC, LLC among others.

Key Companies to Watch

Cleveland Clinic

Overview: Cleveland Clinic is a Cleveland, Ohio-based nonprofit clinical medical center. The Cleveland Clinic Foundation, a non-profit group founded in 1921 in Ohio, maintains and manages a 170-acre (69-hectare) complex in Cleveland, as well as 11 associated hospitals, 19 family health centers in Northeast Ohio, and hospitals in Florida and Nevada. Cleveland Clinic also runs two Cleveland Clinic Canada locations in Toronto and the Cleveland Clinic Abu Dhabi hospital outside of the United States.

Product Portfolio: Endovascular aneurysm repair (EVAR)- It is a minimally invasive aneurysm repair surgery. A surgeon makes a small incision in your groin and inserts a catheter (thin, flexible tube) into an artery.

The global Vascular Injury Treatment market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Injury
  • 3.2. Market Snippet by Treatment Methods
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing demand for advanced treatment methods
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of effective therapeutics
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Injury

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury Segment
  • 7.3. Market Attractiveness Index, By Injury Segment
    • 7.3.1. Thrombosis
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Contusion/Intimal Flap
    • 7.3.3. Laceration/Transection
    • 7.3.4. Spasm
    • 7.3.5. Aneurysm and Pseudoaneurysm
    • 7.3.6. Arteriovenous (AV) Fistula
    • 7.3.7. Others

8. By Treatment Methods

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods Segment
  • 8.3. Market Attractiveness Index, By Treatment Methods Segment
    • 8.3.1. Patch Angioplasty
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Lateral Arteriorrhaphy/ Venorrhaphy
    • 8.3.3. Bypass Graft
    • 8.3.4. Thrombectomy
    • 8.3.5. Extraanatomic Bypass
    • 8.3.6. Others

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Cleveland Clinic
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Massachusetts General Hospital
  • 11.3. Heidelberg University Hospital
  • 11.4. Royal Berkshire NHS Foundation Trust
  • 11.5. Mayo Clinic Health System
  • 11.6. Tenet Healthcare
  • 11.7. Apollo Hospitals Enterprise Ltd.
  • 11.8. Universal Health Services, Inc.
  • 11.9. Mediclinic International
  • 11.10. CHSPSC, LLC(*List Is Not Exhaustive)

12. Premium Insights

13. DataM Intelligence

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us